Peptide library / Thymosin Alpha-1

Thymosin Alpha-1

Thymosin alpha-1 is a 28-amino-acid thymic peptide; thymalfasin refers to specific medicinal preparations in some jurisdictions.

Peptide & blend guide

The short version

Why people discuss it
Discussed for immune support and recurrent-infection concerns; disease-specific treatment evidence is a separate question. Community interest does not establish benefit or a suitable treatment.
What it is
Thymosin alpha-1 is a 28-amino-acid thymic peptide; thymalfasin refers to specific medicinal preparations in some jurisdictions.
Biggest caution
Immune-modulation findings do not establish a general immune boost, and medicinal-product evidence cannot be assigned to an unverified vial. Indication, formulation and jurisdiction must remain visible.
Stack context
Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.

Dose and frequency reference

Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.

Sources report different amounts or schedules; the reference below is a named example, not a consensus.

Subcutaneous injection

Community reference · Not clinical guidance
Amount
1.6 mg
Frequency
Twice weekly
Duration / phase
Reported example: 8–12 weeks on, 4 weeks off

Twice-weekly amount is supported as a reported convention by Peptidepedia and the PeptideDosages overview. The latter’s protocol instead gives smaller daily amounts. Disease-specific medical courses may be longer. Reference only; this does not establish safety, effectiveness or individual suitability.

Community source · reviewed 2026-09-27
Compare reported schedules

Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.

Evidence & sources · Community source profile

AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.

Back to the peptide library